Rx drug information, pharmaceutical research, clinical trials, news, and more
Once-weekly dalbavancin versus daily conventional therapy for skin infection. [2014]
Dalbavancin. [2008]
Dalbavancin: a review for dermatologists. [2006]
Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections. [2005]
Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers. [2004]
Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design. [2012]
Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections. [2006]
Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens. [2005]
Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections. [2003]
Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. [2010]
All Rights reserved - Copyright DrugLib.com, 2006-2017